Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.
| Revenue (TTM) | $37.54B |
| Gross Profit (TTM) | $24.50B |
| EBITDA | $10.41B |
| Operating Margin | 19.30% |
| Return on Equity | 10.60% |
| Return on Assets | 5.12% |
| Revenue/Share (TTM) | $29.30 |
| Book Value | $38.64 |
| Price-to-Book | 2.41 |
| Price-to-Sales (TTM) | 3.21 |
| EV/Revenue | 3.792 |
| EV/EBITDA | 14.06 |
| Quarterly Earnings Growth (YoY) | 40.70% |
| Quarterly Revenue Growth (YoY) | 13.70% |
| Shares Outstanding | $1.28B |
| Float | $1.28B |
| % Insiders | 0.39% |
| % Institutions | 88.76% |
Volatility is currently contracting
GALWAY, Ireland, Sept. 4, 2026 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the following investor conferences: 2026 Wells Fargo Healthcare Conference Tuesday, September 8, 2026, at ~11:45 a.m.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Medtronic NYSE: MDT is a good buy in late 2026 because stars such as value, growth, guidance, partnerships, and dividends are aligning. They point to sustained outperformance and potential acceleration but, more importantly, to robust capital returns.
MDT beats Q1 earnings and revenue estimates as broad-based growth drives shares higher and prompts a fiscal 2027 guidance boost.
Although the revenue and EPS for Medtronic (MDT) give a sense of how its business performed in the quarter ended July 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Medtronic NYSE: MDT reported fiscal 2027 first-quarter revenue of $9.8 billion and adjusted earnings per share of $1.45, as the medical-device maker cited broad-based demand, commercial execution and momentum in several growth platforms.
Medtronic (MDT) came out with quarterly earnings of $1.45 per share, beating the Zacks Consensus Estimate of $1.39 per share. This compares to earnings of $1.26 per share a year ago.
Medtronic raised its outlook for the year after posting higher fiscal first-quarter profit and sales, driven by broad-based demand and contributions from newer growth platforms.
Medtronic stock advances after the company posts better-than-expected quarterly earnings, raises revenue guidance, and announces a $700 million investment.
Strength across the company's largest franchises, new growth platforms, and recent portfolio investments support the long-term growth trajectory GALWAY, Ireland, Sept. 1, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its first quarter (Q1) of fiscal year 2027 (FY27), which ended July 31, 2026.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on MDT and any ticker you trade — then tracks every position and per-strategy win rate.
